The price of the innovative breast cancer drug Kadcyla is too high for it to be made routinely available for use on the NHS in England, the National Institute for Health and Care Excellence (NICE) has announced.
from Boots - WebMD Health http://ift.tt/1Yk10dN via 3 week diet system download
from Tumblr http://ift.tt/1NwSKlv
No comments:
Post a Comment